Frontiers in Pharmacology | Neuropharmacology

Original Research

Published on 17 Jun 2025

Effects of previous steroid treatment on ischemic stroke outcomes: a propensity score-matched hospital analysis

in Neuropharmacology

Yasser Alatawi
Eman A. Alraddadi
Abdullah A. Alhifany
Faisal E. Alzahrani
Saud M. Alknawy
Nawaf M. Aljohani
Husun K. Kecheck
Alanoud K. Alaslab
Aser F. Alamri
Ahmed Aljabri

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1615170

506 views

Original Research

Accepted on 16 Jun 2025

Validating the antiseizure effects of vitexin and related flavone glycosides in zebrafish

in Neuropharmacology

Audrey Breckenridge
Sanskriti Basnyat
Eva Fitch
Colleen CarpenterSwanson

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1628324

Review

Accepted on 16 Jun 2025

Gut-Brain Axis in Post-traumatic Stress Disorder: Microbial -Mediated Mechanisms and New Therapeutic Approaches -A Narrative Review

in Neuropharmacology

Jiayue Pan
Shuairong Lin
Qiuling Qian
Shanni Fu
Xiaoliu Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1621678

Original Research

Accepted on 14 Jun 2025

Dexmedetomidine Potently and Reversibly Regulates Stress-Mediated Behaviors

in Neuropharmacology

Frank D. Yocca
Dinesh K. Dhull
Subhendu Seth
Manisha Chugh
Sameer Sharma
Krishnan Nandabalan
Friso R. Postma
Michael De Vivo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1589075

199 views

Review

Published on 13 Jun 2025

Guarding minds: a narrative review on how n-acetylcyteine and ketones could shield sensitive patients from antibiotic neurotoxicity

in Neuropharmacology

Astrid Lounici

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1613152

431 views

Original Research

Published on 12 Jun 2025

Mitochondrial fission inhibitor Mdivi-1 alleviates lipopolysaccharide-induced parvalbumin interneurons dysregulation and cognitive impairments in a mouse model of sepsis-associated encephalopathy

in Neuropharmacology

Lei Dai
Shuxin Gu
Yibao Zhang
Siqi Ma
Peishan Wang
Jingyun Zhang
Cai Wang
Gaowei Su
Qun Fu
Wei Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1525028

286 views

Original Research

Published on 11 Jun 2025

Neuroprotective potential of quercetin in Alzheimer’s disease: targeting oxidative stress, mitochondrial dysfunction, and amyloid-β aggregation

in Neuropharmacology

Mohd Adnan
Arif Jamal Siddiqui
Fevzi Bardakci
Malvi Surti
Riadh Badraoui
Mitesh Patel

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1593264

779 views

Original Research

Published on 11 Jun 2025

Association between SGLT-2 inhibitors and suicide risk in type 2 diabetes and bipolar: a real-world cohort study

in Neuropharmacology

En-Wei Chang
Jing-Yang Huang
Shih-Chang Lo
Chien-Ning Huang
Yi-Sun Yang
Edy Kornelius

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1601118

432 views

Original Research

Published on 10 Jun 2025

Kininogen enhances seizure susceptibility in mice possibly through bradykinin-induced modulation of calcium transients in glutamatergic and GABAergic neurons

in Neuropharmacology

Arijit Ghosh
Jiwen Huang
Qian Wang
Yanling Gong
Srishti Jain
Abhimanyu Thakur
Amiyangshu De
Meixi Gong
Yoshie Kiyohara
Jingtai Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1509837

743 views

Review

Published on 10 Jun 2025

The role of the tryptophan metabolites in gut microbiota-brain axis and potential treatments: a focus on ischemic stroke

in Neuropharmacology

Na Qin
Xiaodi Xie
Rong Deng
Shiman Gao
Ting Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578018

676 views

General Commentary

Published on 09 Jun 2025

Commentary: Tauroursodeoxycholic acid regulates macrophage/monocyte distribution and improves spinal microenvironment to promote nerve regeneration through inhibiting NF-κB signaling pathway in spinal cord injury

in Neuropharmacology

Yi Chen
Lei Wu
Ruijie Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1620107

647 views

Mini Review

Published on 09 Jun 2025

The role of Poly-ADP ribose polymerase (PARP) enzymes in chemotherapy-induced cognitive impairments – parallels with other neurodegenerative disorders

in Neuropharmacology

Dahlia A. Ordaz
Kalpna Gupta
Daniela A. Bota

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1615843

673 views

Editorial

Accepted on 06 Jun 2025

Editorial: Innovative Therapies Against Neurodegenerative Disorders: from New Active Molecules to Novel Drug Delivery Systems

in Neuropharmacology

Panoraia I. Siafaka
Mehmet Evren Okur
Neslihan Üstündağ Okur

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1640758

178 views

Original Research

Accepted on 06 Jun 2025

Synergistic effects of combined hypnotic drugs on sleep in mice

in Neuropharmacology

Rui Bai
Chu Wang
Fanghui Wu
Yifeng Yin
Yanli Liu
Yuan Gao
Yunyang Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596813

127 views

Mini Review

Accepted on 06 Jun 2025

Clinical characterization and management of persons with comorbid epilepsy and depression: an expert opinion paper

in Neuropharmacology

Gaia Sampogna
Roberto Brugnoli
Giuseppe Didato
Maurizio Elia
Edoardo Ferlazzo
Gianluca Serafini
Giampaolo Vatti
Umberto Volpe
Flavio Villani
Gabriele Sani

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592650

118 views

Systematic Review

Published on 06 Jun 2025

Bibliometric analysis of NMDA receptors: 2015–2024

in Neuropharmacology

Yunsheng Liu
Yanyan Jia
Zengwei Kou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1614831

830 views